WO2008133744A3 - Sample preparation for antigen detection testing - Google Patents

Sample preparation for antigen detection testing Download PDF

Info

Publication number
WO2008133744A3
WO2008133744A3 PCT/US2007/086894 US2007086894W WO2008133744A3 WO 2008133744 A3 WO2008133744 A3 WO 2008133744A3 US 2007086894 W US2007086894 W US 2007086894W WO 2008133744 A3 WO2008133744 A3 WO 2008133744A3
Authority
WO
WIPO (PCT)
Prior art keywords
sample preparation
antigen detection
detection testing
samples
pooled
Prior art date
Application number
PCT/US2007/086894
Other languages
French (fr)
Other versions
WO2008133744A2 (en
Inventor
William E Hessman
Original Assignee
Central States Testing Llc
William E Hessman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Central States Testing Llc, William E Hessman filed Critical Central States Testing Llc
Publication of WO2008133744A2 publication Critical patent/WO2008133744A2/en
Publication of WO2008133744A3 publication Critical patent/WO2008133744A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding

Abstract

The present invention provides methods for reducing false negative errors in antigen capture tests of pooled and single samples. The methods are particularly useful for detecting antigen-containing samples when pooled with other samples that contain an inhibiting agent.
PCT/US2007/086894 2006-12-08 2007-12-08 Sample preparation for antigen detection testing WO2008133744A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86931906P 2006-12-08 2006-12-08
US60/869,319 2006-12-08

Publications (2)

Publication Number Publication Date
WO2008133744A2 WO2008133744A2 (en) 2008-11-06
WO2008133744A3 true WO2008133744A3 (en) 2008-12-31

Family

ID=39926252

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/086894 WO2008133744A2 (en) 2006-12-08 2007-12-08 Sample preparation for antigen detection testing

Country Status (1)

Country Link
WO (1) WO2008133744A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5415996A (en) * 1993-10-20 1995-05-16 Olsson; Lennart Prognostic markers in human breast cancer
US20030152942A1 (en) * 2001-05-09 2003-08-14 Lance Fors Nucleic acid detection in pooled samples

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5415996A (en) * 1993-10-20 1995-05-16 Olsson; Lennart Prognostic markers in human breast cancer
US20030152942A1 (en) * 2001-05-09 2003-08-14 Lance Fors Nucleic acid detection in pooled samples

Also Published As

Publication number Publication date
WO2008133744A2 (en) 2008-11-06

Similar Documents

Publication Publication Date Title
MX2011010826A (en) Diagnostic devices and related methods.
BRPI0809138B8 (en) method for detecting the presence or amount of one or more analytes in a biological sample
WO2006088904A3 (en) Fecal sample test device and methods of use
WO2008096225A3 (en) Drug detection kit and method
NZ629703A (en) Methods and compositions for detecting multiple analytes with a single signal
WO2006098772A3 (en) Systems and methods for measurement optimization
WO2007005666A3 (en) System and method of analyte detection using differential receptors
WO2006089027A3 (en) Lateral flow test kit and method for detecting an analyte
WO2009029550A3 (en) Highly sensitive system and methods for analysis of prostate specific antigen (psa)
MX2009009125A (en) Signal outage detection.
WO2007116324A3 (en) Consumer food testing device
EP2344679A4 (en) Kits and devices for detecting analytes
EP2182365A3 (en) Sample analyzer
WO2008117067A3 (en) Protein signature/markers for the detection of adenocarcinoma
WO2010051544A3 (en) Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer
WO2008011158A3 (en) Method of detecting and/ or measuring hepcidin in a sample
TW200741203A (en) Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody
WO2007090126A3 (en) Compositions and methods for detecting and quantifying toxic substances in disease states
EP1873533A4 (en) Testing chip for analysis of sample, and microanalysis system
EP2273168A3 (en) Valve failure detection
WO2009113044A3 (en) Method for a highly sensitive detection and quantification of biomolecules using secondary ion mass spectrometry (sims)
WO2009007846A3 (en) Methods for modifying, isolating, detecting, visualizing, and quantifying citrullinated and/or homocitrullinated peptides, polypeptides and proteins
WO2011062407A3 (en) Method and device for detecting analytes
WO2012032345A3 (en) Biomarker signatures and uses thereof
WO2009103843A3 (en) Method and device for detection of an analyte

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07874356

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07874356

Country of ref document: EP

Kind code of ref document: A2